Minerva Neurosciences (NERV) Climbs in Pre-Market Trading for June 23

Equities Staff  |

Shares of Minerva Neurosciences Inc (NASDAQ:NERV) are on the move in pre-market trading for June 23.

Ahead of the market's open, Minerva Neurosciences stock is up 20.00% from the previous session’s close.

Minerva Neurosciences fell $0.15 in the last session and aims to gain back ground today.

For technical charts, analysis, and more on Minerva Neurosciences visit the company profile.

Pre-market prices and movements as of 07:36:45 est.

About Minerva Neurosciences Inc

Minerva's portfolio of compounds includes: roluperidone (MIN-101), in clinical development for schizophrenia, and MIN-301, in pre-clinical development for Parkinson's disease.

To get more information on Minerva Neurosciences Inc and to follow the company's latest updates, you can visit the company's profile page here: Minerva Neurosciences Inc's Profile. For more news on the financial markets be sure to visit Equities News. Also, don't forget to sign-up for the Daily Fix to receive the best stories to your inbox 5 days a week.

Sources: Symbol info widget is provided by TradingView based on 15-minute-delayed prices. All other article data is provided by IEX Cloud on 15-minute delayed prices or EOD company info.

Stock price data is provided by IEX Cloud on a 15-minute delayed basis. Chart price data is provided by TradingView on a 15-minute delayed basis.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer

Trending Articles

Investors Must Understand 5G Wireless Growth Wave: Jeff Kagan
'Goldilocks' Stocks Will Define This Decade
What You Need To Know About Bear Markets
Is Your iPhone Already Obsolete?

Market Movers

Sponsored Financial Content